Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 97.56 | -17.63 |
PEG Ratio (TTM) | 0.77 | -5.55 |
P/S Ratio (TTM) | 7.60 | 39.14 |
P/B Ratio (TTM) | 12.34 | 5.84 |
P/FCF Ratio (TTM) | -138.07 | -147.32 |
Price to 5YR AVG Earnings Ratio | N/A | -34.54 |
Price to 5YR AVG FCF Ratio | N/A | -1.05 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | 1.59% | 289.87% |
ROE (TTM) | 8.57% | -4,257.42% |
Net Profit Margin (TTM) | 1.38% | -1,046.83% |
ROIC 5YR AVG | N/A | -16.46% |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 377.24% | 7.94% | N/A |
Revenue | 10.59% | 100.35% | N/A |
Net Income | 373.13% | 6.61% | N/A |
Cash Flow | -38.99% | -290.17% | N/A |
Health (28%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.37 | 4.95 |
Quick Ratio (TTM) | 1.26 | 4.92 |
D/E Ratio (TTM) | N/A | 1.30 |
Interest Coverage (TTM) | N/A | -11.54 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 7.47 | 21.07 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 896.41% |